Therapy of Mucormycosis

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective rand...

Full description

Bibliographic Details
Main Authors: Nikolaos V. Sipsas, Maria N. Gamaletsou, Amalia Anastasopoulou, Dimitrios P. Kontoyiannis
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Journal of Fungi
Subjects:
Online Access:http://www.mdpi.com/2309-608X/4/3/90